Investing made simple: The Motley Fool's essential guide to investing is now available to the public, free of cost, at
http://bit.ly/1atRpHZ. This resource was designed to cover everything that new investors need to know to get started today. For your free copy, just click the link above.
------------------------------------------------------------------------
There has been a lot of buzz in recent days about the idea of a bubble in the biotech space on the market today. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB), an ETF that tracks a range of companies in the biotech space, peaked exactly a month ago, and has since lost 12% of its value, falling 3% in a single day yesterday. Investors are understandably concerned that the sell-off will lead to a continued decline in the days ahead.
In this video, Motley Fool healthcare analyst David Williamson discusses why there may be some validity to the speculation of a bubble in this sector at the moment. David then gives investors his three top picks for which companies he would jump in on if a biotech pullback offered a lower price point, and why these three pharmaceutical businesses have the underlying strength to survive any market condition.
Visit us on the web at http://www.fool.com, home to the world's greatest investing community!
------------------------------------------------------------------------
Subscribe to The Motley Fool's YouTube Channel:
http://www.youtube.com/TheMotleyFool
Or, follow our Google+ page:
https://plus.google.com/+MotleyFool/p...
Inside The Motley Fool: Check out our Culture Blog!
http://culture.fool.com
Join our Facebook community:
https://www.facebook.com/themotleyfool
Follow The Motley Fool on Twitter:
https://twitter.com/themotleyfool
Best Buys for a Biotech Bubble | 3/25/14 | The Motley Fool healthcare stocks in recession | |
| 9 Likes | 9 Dislikes |
| 3,245 views views | 205K followers |
| News & Politics | Upload TimePublished on 25 Mar 2014 |
Không có nhận xét nào:
Đăng nhận xét